Patents for C07K 19 - Hybrid peptides (29,428) |
---|
03/19/2014 | CN102199215B MAPWA fusion antibacterial peptide, preparation method and application thereof |
03/18/2014 | US8673303 Cripto blocking antibodies and uses thereof |
03/18/2014 | CA2767061C Specific binding agents of human angiopoietin-2 |
03/18/2014 | CA2703263C Immunosuppressive polypeptides and nucleic acids |
03/18/2014 | CA2553261C Immunokinases |
03/18/2014 | CA2481827C Polyvalent cation-sensing receptor in atlantic salmon |
03/13/2014 | WO2014039961A1 Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof |
03/13/2014 | WO2014039715A1 Methods and compositions for site-specific labeling of peptides and proteins |
03/13/2014 | WO2014038890A1 Fusion protein comprising axl and composition for treating cancer comprising same |
03/13/2014 | WO2014038888A1 Fusion protein comprising ros1 and composition for treating cancer comprising same |
03/13/2014 | WO2014038887A1 Fusion protein comprising fgfr2 and composition for treating cancer comprising same |
03/13/2014 | WO2014038884A1 Fusion protein and composition for diagnosing cancer comprising same |
03/13/2014 | WO2014036847A1 Fusion protein of human cytomegalovirus immunogen as well as preparation method therefor and use thereof |
03/13/2014 | WO2013181461A3 Metal abstraction peptide with superoxide dismutase activity |
03/12/2014 | EP2706116A1 Binding domain-immunoglobulin fusion proteins |
03/12/2014 | EP2706069A1 Protein complexes and methods of manufacturing bispecific antibodies using the protein complexes |
03/12/2014 | CN103635590A Rapid and accurate analysis of protein sialylation |
03/12/2014 | CN103635490A Soluble proteins for use as therapeutics |
03/12/2014 | CN103626878A Newcastle disease virus F protein and enterotoxin LTB fusion protein and application thereof |
03/12/2014 | CN103626877A NY-ESO-1-containing fusion protein as well as preparation method and application thereof |
03/12/2014 | CN103626876A Bacterial toxin vaccine |
03/12/2014 | CN103626875A Immunoglobulin fusion proteins |
03/12/2014 | CN103623396A Pharmaceutical composition containing recombinant tissue plasminogen activator |
03/12/2014 | CN103159859B Sendai virus antigen peptide composition and application thereof in detecting Sendai virus infection |
03/12/2014 | CN103087198B MRSA (Methicillin Resistant Staphylococcus Aureus) vaccine recombinant protein antigen I1C and preparation method and application thereof |
03/12/2014 | CN102977214B Recombinant protein HF2 used for methicillin-resistant staphylococcus aureus (MRSA) vaccine, and preparation method and application thereof |
03/12/2014 | CN102964453B Osteogenic growth peptide-calcitonin gene related peptide fusion protein and encoding gene thereof |
03/12/2014 | CN102741272B Peptides inhibiting adhesion of aspergillus fumigatus to cornea |
03/12/2014 | CN101998965B Immunosuppressive polypeptides and nucleic acid |
03/11/2014 | CA2562552C Hybrid recombinases for genome manipulation |
03/11/2014 | CA2495198C Novel lipases and uses thereof |
03/11/2014 | CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
03/11/2014 | CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells |
03/06/2014 | WO2014035474A1 Compositions and methods for treating cancer |
03/06/2014 | WO2014035361A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
03/06/2014 | WO2014035179A1 Mitochondrial targeting peptide |
03/06/2014 | WO2014034609A1 P53 family chimeric molecule and use thereof |
03/06/2014 | WO2014033281A1 Methods and peptides for preventing and treating a bcr-abl and a c-abl associated disease |
03/06/2014 | WO2014026033A9 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
03/05/2014 | EP2702074A1 Novel immunoconjugates |
03/05/2014 | CN103614440A Fusion protein identification method |
03/05/2014 | CN103613671A Al-18F mark fusion peptide and application thereof |
03/05/2014 | CN103613670A HSA (Human Serum Albumin) long-acting fusion protein and rapid assembly, separation and purification method thereof |
03/05/2014 | CN103613669A Polypeptide for inhibiting cell proliferation and inducing apoptosis and preparation method and use thereof |
03/05/2014 | CN103613668A Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof |
03/05/2014 | CN103613646A Optimized non-canonical zinc finger proteins |
03/05/2014 | CN102408467B Method for drying protein in vacuum, protein product prepared and kit |
03/05/2014 | CN102190735B Fusion protein TAT (transactivator of transcription)-OCT4 (octamer-binding transcription factor 4), and coding gene and application thereof |
03/04/2014 | US8664360 BSL3 polypeptides |
03/04/2014 | CA2409236C Protein translocation into plant cells |
02/27/2014 | WO2014032021A1 Antibody drug conjugates (adc) that bind to 158p1d7 proteins |
02/27/2014 | WO2014030780A1 Screening and engineering method of super-stable immunoglobulin variable domains and their uses |
02/27/2014 | WO2014030728A1 Fcγriib-specific fc region variant |
02/27/2014 | WO2014003538A8 Rapid specific pathogen free animal |
02/27/2014 | WO2013158766A9 Synthetic brassica-derived chloroplast transit peptides |
02/26/2014 | EP2700710A1 Anti-cyanobacteria recombinant antibody polypeptide, gene thereof, and preparation method thereof |
02/26/2014 | EP2700655A1 Surface-active collagen membrane by peptide |
02/26/2014 | CN103608463A Method for preparing polymeric protein composed of monomeric protein produced by fusing protein having immunoglobulin fold structure to protein capable of serving as subunit structure |
02/26/2014 | CN103601809A HCV multi-epitope peptide, truncated NS3, and DC activating molecule EDA recombinant protein vaccine and applications thereof |
02/26/2014 | CN103601808A Novel natriuretic peptide, preparation method and applications thereof in preparation of genetic engineering drugs |
02/26/2014 | CN102245764B Hybrid alpha-amylases |
02/25/2014 | US8658598 Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies |
02/25/2014 | CA2609271C Novel substrate for rpn 11 enzymatic activity |
02/25/2014 | CA2376665C Novel tet repressor-based transcriptional regulatory proteins |
02/20/2014 | WO2014027789A1 Interferon-alpha fusion protein in which cytoplasmic transduction peptide and polyethylene glycol are bonded to one another |
02/20/2014 | WO2014026286A1 Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin |
02/20/2014 | US20140051637 Brain-targeting functional nucleic acid and use thereof |
02/19/2014 | EP2698386A1 Fusion protein |
02/19/2014 | CN103589742A Gene of intracellular domain of chimera antigen receptor and coding protein of gene |
02/19/2014 | CN102702360B Novel mycobacterium tuberculosis specific fusion protein as well as preparation and application thereof |
02/19/2014 | CN102532324B Preparation and application of brucella gene engineering subunit vaccines |
02/19/2014 | CN102367278B Method for cultivating disease-resisting wheat and special recombinant plasmid thereof |
02/19/2014 | CN102276726B Fusion protein of hepatocyte growth factor receptor active group |
02/19/2014 | CN101889091B Nanocarrier based plant transfection and transduction |
02/18/2014 | CA2708753C Peptide diagnostic agent for lyme disease |
02/18/2014 | CA2674838C Anti-ige vaccines |
02/18/2014 | CA2454756C Methods and compounds for the targeting of protein to exosomes |
02/18/2014 | CA2413450C Streptococcus antigens |
02/13/2014 | WO2014026033A1 Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats |
02/13/2014 | WO2014023673A1 Interleukin-10 fusion proteins and uses thereof |
02/13/2014 | WO2014023129A1 α-CONOTOXIN PEPTIDE, AND MEDICAL COMPOSITION AND PURPOSE THEREOF |
02/13/2014 | WO2013191591A9 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae |
02/13/2014 | WO2013186545A3 Chaperone/usher fusion proteins |
02/13/2014 | WO2013080147A3 Anticancer fusion protein |
02/13/2014 | US20140045763 Compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type i (dmi) |
02/13/2014 | US20140045749 Growth factor complex |
02/13/2014 | US20140045247 Fusion protein |
02/13/2014 | CA2876285A1 Interleukin-10 fusion proteins and uses thereof |
02/12/2014 | EP2695894A1 Modified laminin and use thereof |
02/12/2014 | EP2694557A2 Local demand side power management for electric utility networks |
02/12/2014 | EP2694556A1 Quantitative standard for mass spectrometry of proteins |
02/12/2014 | EP2694543A2 Single chain antibodies for photosynthetic microorganisms and methods of use |
02/12/2014 | CN103582652A Quantitative standard for mass spectrometry of proteins |
02/12/2014 | CN103571863A Novel pharmaceutical protein DRACO and applications thereof in prevention and treatment of porcine reproductive and respiratory syndrome |
02/12/2014 | CN103570836A Recombinant porcine interferon beta1-Fc fusion protein as well as encoding gene and expressing method thereof |
02/12/2014 | CN103570835A Staphylococcus aureus ITC (Inverse Transition Cycling) fusion protein as well as preparation method and application thereof |
02/12/2014 | CN103570808A Alpha-conotoxin peptide TxIB/Txd4, as well as pharmaceutical composition and use thereof |
02/12/2014 | CN103566363A Preparation method of contraceptive microneedle |
02/12/2014 | CN102816240B Fusion protein and fusion protein expression vector thereof |
02/11/2014 | US8648174 Ucp4 |